Part,  Chapter, Paragraph

1   II,     6.Acr    |    and Rubella Vaccine~MRSA~Methycillin-Resistant Staphylococcus Aureus~PLHIV~
2   II,     6.  3.  2| received prime attention is methycillin-resistant Staphylococcus aureus (MRSA).